Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 3
2011 4
2012 3
2013 3
2014 1
2015 8
2016 8
2017 7
2018 7
2019 9
2020 17
2021 15
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database.
Baliga S, Abou-Foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Blakaj D, Brennan S, Brunet A, De Oliveira TB, Burtness B, Maseda AC, Chow VL, Chua ML, de Ridder M, Garikipati S, Hanai N, Ho FCH, Huang SH, Kiyota N, Klinghammer K, Kowalski LP, Kwong DL, McDowell LJ, Merlano MC, Nair S, Economopoulou P, Overgaard J, Psyrri A, Tribius S, Waldron J, Yom SS, Mehanna H. Baliga S, et al. Among authors: economopoulou p. Eur J Cancer. 2024 Mar 30;203:114038. doi: 10.1016/j.ejca.2024.114038. Online ahead of print. Eur J Cancer. 2024. PMID: 38579517 Free article.
Editorial: Women in head and neck cancer, volume II: 2022.
Economopoulou P, Kotsantis I, Psyrri A. Economopoulou P, et al. Front Oncol. 2023 Sep 12;13:1278798. doi: 10.3389/fonc.2023.1278798. eCollection 2023. Front Oncol. 2023. PMID: 37771432 Free PMC article. No abstract available.
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou GA, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou NG, Panayiotides IG, Perisanidis C, Fernandez AI, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung TN, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm DL, Foukas PG, Psyrri A. Moutafi M, et al. Among authors: economopoulou p. Cancer Res Commun. 2023 Aug 10;3(8):1514-1523. doi: 10.1158/2767-9764.CRC-23-0051. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37575280 Free PMC article. Clinical Trial.
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.
Gavrielatou N, Vathiotis I, Aung TN, Shafi S, Burela S, Fernandez AI, Moutafi M, Burtness B, Economopoulou P, Anastasiou M, Foukas P, Psyrri A, Rimm DL. Gavrielatou N, et al. Among authors: economopoulou p. Cancer Res Commun. 2023 Apr 11;3(4):558-563. doi: 10.1158/2767-9764.CRC-22-0299. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37057033 Free PMC article.
Significance of MYB and NTRK Expression in Head and Neck Adenoid Cystic Carcinoma.
Pantazopoulos T, Leventakou D, Koufopoulos N, Pouliakis A, Economopoulou P, Glava C, Tzardi M, Kafiri G, Kittas C, Korkolopoulou P, Arapantoni-Dadioti P, Sotiriou H, Filippidis T, Maragoudakis P, Giotakis I, Panayiotides IG, Psyrri A, Delides A. Pantazopoulos T, et al. Among authors: economopoulou p. Anticancer Res. 2023 Apr;43(4):1709-1717. doi: 10.21873/anticanres.16323. Anticancer Res. 2023. PMID: 36974793
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Economopoulou P, Spathis A, Kotsantis I, Maratou E, Anastasiou M, Moutafi MK, Kirkasiadou M, Pantazopoulos A, Giannakakou M, Edelstein DL, Sloane H, Fredebohm J, Jones FS, Kyriazoglou A, Gavrielatou N, Foukas P, Panayiotides I, Psyrri A. Economopoulou P, et al. Oral Oncol. 2023 Apr;139:106358. doi: 10.1016/j.oraloncology.2023.106358. Epub 2023 Mar 3. Oral Oncol. 2023. PMID: 36871349
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Mountzios G, Planchard D, Metro G, Tsiouda D, Prelaj A, Lampaki S, Shalata W, Riudavets M, Christopoulos P, Girard N, Albarrán-Artahona V, Garcia Campelo R, Samitas K, Banna GL, Boukovinas I, Agbarya A, Koumarianou A, Perdikouri EI, Kosmidis P, Linardou H, Mauri D, Mavroudis D, Athanasiadis I, Kalofonos H, Xenidis N, Korantzis I, Ardavanis A, Rallis G, Bottiglieri A, Efthymiadis K, Oikonomopoulos G, Kokkalis A, Saloustros E, Tsoukalas N, Bartzi D, Economopoulou P, Psyrri A, Reck M, Lo Russo G. Mountzios G, et al. Among authors: economopoulou p. JTO Clin Res Rep. 2022 Nov 20;4(1):100433. doi: 10.1016/j.jtocrr.2022.100433. eCollection 2023 Jan. JTO Clin Res Rep. 2022. PMID: 36793384 Free PMC article.
Editorial: Women in head and neck cancer 2021.
Economopoulou P, Kotsantis I, Psyrri A. Economopoulou P, et al. Front Oncol. 2022 Dec 13;12:1024210. doi: 10.3389/fonc.2022.1024210. eCollection 2022. Front Oncol. 2022. PMID: 36582802 Free PMC article. No abstract available.
90 results